Celsion announces presentation of long-term follow-up data from Phase I ThermoDox dos

[News]

Celsion Corporation today announced that Dr. Ronnie T.P. Poon, a principal investigator of the Phase I ThermoDox® dose escalation trial, held a press conference at the University of Hong Kong to provide an update on the long-term follow-up data from patients treated at his center as well as present illustrative patient case studies. The Phase I trial was conducted in 2006.

More... (http://www.news-medical.net/news/20100416/Celsion-announces-presentation-of-long-term-follow-up-data-from-Phase-I-ThermoDox-dose-escalation-trial.aspx)